Fingolimod: impact on beta-amyloid neurotoxicity?


A new study in mouse cortical neurons suggests that fingolimod, a sphingosine-1-phosphate (S1P) receptor modulator currently used to treat MS, may reduce beta-amyloid neurotoxicity (Doi et al. PLoS One 2013;8:e6; free full text at

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page